Published in Drug Law Weekly, November 21st, 2006
The company reported net income for the quarter of approximately $7.2 million, or 72 cents per share, compared to net income of $5.6 million, or 58 cents per share, in the third quarter of 2005.
For the 9 months ended September 30, 2006, revenues increased to approximately $60 million, or 29% above the $46.4 million recognized for the first 9 months of 2005....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.